Recent Circulars
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to … | |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to show cause notice and non-existence at registered office address.
| |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to … | |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to show cause notice and confirmed non-existence at registered office address.
| |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to … | |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to show cause notice and non-existence at registered office.
| |||||||||||||||
SEBI releases attachment/freeze on assets of Uttam Dealers Pvt. Ltd. (PAN: AABCU1506F) in recovery proceedings related to the Illiquid Stock … | |||||||||||||||
SEBI releases attachment/freeze on assets of Uttam Dealers Pvt. Ltd. (PAN: AABCU1506F) in recovery proceedings related to the Illiquid Stock Options matter.
| |||||||||||||||
BSE notifies removal of PAN-India Drugs & Chemicals Limited from its Dissemination Board effective March 12, 2026, pursuant to SEBI circular … | |||||||||||||||
BSE notifies removal of PAN-India Drugs & Chemicals Limited from its Dissemination Board effective March 12, 2026, pursuant to SEBI circular on exclusively listed companies exercising exit option.
| |||||||||||||||
PAN-India Drugs & Chemicals Limited will be removed from the BSE Dissemination Board effective March 12, 2026, following the exit option … | |||||||||||||||
PAN-India Drugs & Chemicals Limited will be removed from the BSE Dissemination Board effective March 12, 2026, following the exit option exercised under SEBI circular SEBI/HO/MRD/DSA/CIR/P/2016/110.
| |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for BLUEGOD ENTERTAINMENT LIMITED effective March 12, 2026, with … | |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for BLUEGOD ENTERTAINMENT LIMITED effective March 12, 2026, with renunciation period from March 12-13, 2026 and Rights Issue open from March 12-19, 2026.
| |||||||||||||||
BSE notifies trading members that Rights Entitlements (REs) for BLUEGOD ENTERTAINMENT LIMITED will be available for renunciation trading … | |||||||||||||||
BSE notifies trading members that Rights Entitlements (REs) for BLUEGOD ENTERTAINMENT LIMITED will be available for renunciation trading from March 12-13, 2026, with the Rights Issue open March 12-19, 2026.
| |||||||||||||||
BSE notifies trading members about the commencement of dealings in Rights Entitlements (REs) for Nexome Capital Markets Limited, tradable … | |||||||||||||||
BSE notifies trading members about the commencement of dealings in Rights Entitlements (REs) for Nexome Capital Markets Limited, tradable from March 13 to March 18, 2026, settled on T+1 rolling basis.
| |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for Nexome Capital Markets Limited, permitting renunciation from March 13 … | |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for Nexome Capital Markets Limited, permitting renunciation from March 13 to March 18, 2026, with the Rights Issue open from March 13 to March 23, 2026.
| |||||||||||||||